---
figid: PMC9371883__JO2022-8675096.001
pmcid: PMC9371883
image_filename: JO2022-8675096.001.jpg
figure_link: /pmc/articles/PMC9371883/figure/fig1/
number: Figure 1
figure_title: ''
caption: Linderalactone inhibits the viability of pancreatic cancer cells. (a) Morphological
  changes of pancreatic cancer cells exposed to LL. (b) The chemical structure of
  LL. (c) CCK8 assay detected the viability of pancreatic cancer cells under varying
  concentrations and time of LL treatment. Scale bar = 200 μm.
article_title: Linderalactone Suppresses Pancreatic Cancer Development In Vitro and
  In Vivo via Negatively Regulating PI3K/AKT Signaling Pathway.
citation: Dongchao Xu, et al. J Oncol. 2022;2022:8675096.
year: '2022'

doi: 10.1155/2022/8675096
journal_title: Journal of Oncology
journal_nlm_ta: J Oncol
publisher_name: Hindawi

keywords:
---
